ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.90177
0.09%
Brent Oil
82.895
-0.69%
Bitcoin
63,048.59
-0.19%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aduro Biotech Inc (ADRO)

  7. Aduro Biotech Inc (ADRO) Noticias

ADRO

Aduro Biotech (ADRO)

Aduro Biotech Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADRO
FechaHoraFuenteTítuloSímboloCompañía
20/06/202308:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
20/06/202308:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
12/06/202308:42Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADROAduro Biotech Inc
31/05/202318:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
09/05/202315:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADROAduro Biotech Inc
28/04/202316:43Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADROAduro Biotech Inc
17/04/202315:52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADROAduro Biotech Inc
12/04/202315:57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADROAduro Biotech Inc
10/03/202315:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADROAduro Biotech Inc
14/02/202315:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADROAduro Biotech Inc
10/11/202216:00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADROAduro Biotech Inc
10/11/202215:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADROAduro Biotech Inc
07/06/202215:46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADROAduro Biotech Inc
24/05/202215:01Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ADROAduro Biotech Inc
14/04/202215:46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADROAduro Biotech Inc
17/03/202215:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADROAduro Biotech Inc
03/03/202215:35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADROAduro Biotech Inc
09/11/202116:28Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ADROAduro Biotech Inc
15/04/202106:41Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADROAduro Biotech Inc
07/04/202115:55Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADROAduro Biotech Inc
30/03/202116:27Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ADROAduro Biotech Inc
05/11/202016:00Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADROAduro Biotech Inc
15/10/202016:17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADROAduro Biotech Inc
05/10/202008:00GlobeNewswire Inc.Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement FinancingNASDAQ:ADROAduro Biotech Inc
01/10/202015:05GlobeNewswire Inc.Aduro Biotech Stockholders Approve Merger Agreement with Chinook TherapeuticsNASDAQ:ADROAduro Biotech Inc
26/08/202015:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADROAduro Biotech Inc
24/08/202005:10Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ADROAduro Biotech Inc
18/08/202015:48Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ADROAduro Biotech Inc
03/08/202015:05GlobeNewswire Inc.Aduro Biotech Provides Business Update and Reports Second Quarter 2020 Financial ResultsNASDAQ:ADROAduro Biotech Inc
24/06/202007:15GlobeNewswire Inc.Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA NephropathyNASDAQ:ADROAduro Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:ADRO

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
MRK
Merck
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
FX
EURMXN
Euro vs MXN
USOTC
ADDYY
Adidas (QX)
PM
XAUUSD
Gold vs US Dollar
COIN
SOLUSD
Solana
NYSE
NKE
Nike
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados